US2022249394A1PendingUtilityA1
Method for selectively killing protein aggregate-containing cells, kit therefor, therapeutic drug for protein misfolding diseases and drug product for removing protein aggregates from blood product
Est. expiryNov 8, 2039(~13.3 yrs left)· nominal 20-yr term from priority
Inventors:Tsuyoshi Ogawa
A61P 27/02A61P 25/16A61P 25/14A61P 43/00A61K 31/045A61P 31/12A61P 27/12A61P 25/28A61P 7/00A61P 25/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for selectively killing protein aggregate-containing cells, a kit thereof, a therapeutic agent for the protein misfolding disease, and an agent for removing a protein aggregate from a blood derivative are provided. The method for selectively killing cells according to one embodiment acts a fluorine-based alcohol or a compound represented by general formula (1) on cells as a compound for detecting a protein aggregate and selectively kills protein aggregate-containing cells.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for selectively killing protein aggregate-containing cells comprising:
treating cells with a molecular structure-modifying agent, the molecular structure-modifying agent containing a fluorine-based alcohol or a compound represented by general formula (1),
wherein, in general formula (1), a is 0 or 1,
when a is 1, then R 1 is a hydrogen atom and R 2 is a hydroxyl group, or R 1 is a hydroxyl group and R 2 is a hydrogen atom,
when a is 0, then R 2 is an oxygen atom forming a double bond together with a carbon atom,
R 3 is CH l Cl m F n , and l is an integer from 0 to 3, m and n are integers from 1 to 3, and l+m+n=3 is satisfied,
R 4 is CH s Cl t F u , and s is an integer from 0 to 3, t and u are integers from 1 to 3, and s+t+u=3 is satisfied.
l+s<6 is satisfied.
2 . The method for selectively killing protein aggregate-containing cells according to claim 1 , wherein
the fluorine-based alcohol is presented by a general formula RfCH 2 OH or RfRf′CHOH, Rf and Rf′ present a perfluoroalkyl group having 1 to 10 carbon atoms, and Rf and Rf′ are different from each other or the same.
3 . The method for selectively killing protein aggregate-containing cells according to claim 1 , wherein the fluorine-based alcohol is 1,1,1,3,3,3-hexafluoro-2-propanol.
4 . The method for selectively killing protein aggregate-containing cells according to claim 1 , wherein a concentration of the fluorine-based alcohol or a compound represented by general formula (1) when treating the cells is in a range from 1 μM to 100 mM.
5 . A kit for selectively killing protein aggregate-containing cells comprising:
a fluorine-based alcohol or a compound represented by general formula (1),
wherein, in general formula (1), a is 0 or 1,
when a is 1, then R 1 is a hydrogen atom and R 2 is a hydroxyl group, or R1 is a hydroxyl group and R 2 is a hydrogen atom,
when a is 0, then R 2 is an oxygen atom forming a double bond together with a carbon atom,
R 3 is CH l Cl m F n , and l is an integer from 0 to 3, m and n are integers from 1 to 3, and l+m+n=3 is satisfied,
R 4 is CH s Cl t F u , and s is an integer from 0 to 3, t and u are integers from 1 to 3, and s+t+u=3 is satisfied.
l+s<6 is satisfied.
6 . The kit for selectively killing protein aggregate-containing cells according to claim 5 , wherein
the fluorine-based alcohol is presented by a general formula RfCH 2 OH or RfRf′CHOH, Rf and Rf′ present a perfluoroalkyl group having 1 to 10 carbon atoms, and Rf and Rf′ are different from each other or the same.
7 . The kit for selectively killing protein aggregate-containing cells according to claim 1 , wherein the fluorine-based alcohol is 1,1,1,3,3,3-hexafluoro-2-propanol.
8 . The kit for selectively killing protein aggregate-containing cells according to claim 5 , wherein a concentration of the fluorine-based alcohol or a compound represented by general formula (1) when treating the cells is in a range from 1 μM to 100 mM.
9 . A therapeutic agent for a protein misfolding disease comprising:
a fluorine-based alcohol or a compound represented by general formula (1),
wherein, in general formula (1), a is 0 or 1,
when a is 1, then R 1 is a hydrogen atom and R 2 is a hydroxyl group, or R 1 is a hydroxyl group and R 2 is a hydrogen atom,
when a is 0, then R 2 is an oxygen atom forming a double bond together with a carbon atom,
R 3 is CH l Cl m F n , and l is an integer from 0 to 3, m and n are integers from 1 to 3, and l+m+n=3 is satisfied,
R 4 is CH s Cl t F u , and s is an integer from 0 to 3, t and u are integers from 1 to 3, and s+t+u=3 satisfied.
l+s<6 is satisfied.
10 . The therapeutic agent for the protein misfolding disease according to claim 9 , wherein
the fluorine-based alcohol is presented by a general formula RfCH 2 OH or RfRf′CHOH, Rf and Rf′ present a perfluoroalkyl group having 1 to 10 carbon atoms, and Rf and Rf′ are different from each other or the same.
11 . The therapeutic agent for the protein misfolding disease according to claim 9 , wherein the fluorine-based alcohol is 1,1,1,3,3,3-hexafluoro-2-propanol.
12 . An agent for removing a protein aggregate from a blood derivative comprising:
a fluorine-based alcohol or a compound represented by general formula (1),
wherein, in general formula (1), a is 0 or 1,
when a is 1, then R 1 is a hydrogen atom and R 2 is a hydroxyl group, or R 1 is a hydroxyl group and R 2 is a hydrogen atom,
when a is 0, then R 2 is an oxygen atom forming a double bond together with a carbon atom,
R 3 is CH l Cl m F n , and l is an integer from 0 to 3, m and n are integers from 1 to 3, and l+m+n=3 is satisfied,
R 4 is CH s Cl t F u , and s is an integer from 0 to 3, t and u are integers from 1 to 3, and satisfied that s+t+u=3 is satisfied.
l+s<6 is satisfied.
13 . The agent for removing the protein aggregate from the blood derivative according to claim 12 , wherein
the fluorine-based alcohol is presented by a general formula RfCH 2 OH or RfRf′CHOH, Rf and Rf′ present a perfluoroalkyl group having 1 to 10 carbon atoms, and Rf and Rf′ are different from each other or the same.
14 . The agent for removing the protein aggregate from the blood derivative according to claim 12 , wherein the fluorine-based alcohol is 1,1,1,3,3,3-hexafluoro-2-propanol.Join the waitlist — get patent alerts
Track US2022249394A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.